WHITEFISH, Mont. — xD Bio Inc., a privately held, Montana-based company announced today that the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has awarded the company $149,959 over 6 months for the first phase of a Small Business Technology Transfer (STTR) grant. The award supports researchers at xD Bio and collaborators at […]
RESEARCH TRIANGLE PARK, N.C. — RTI International, a leading research institute, today announced a follow-on investment in PierianDx to help empower leading health institutions and diagnostic laboratories to build world-class precision medicine programs. The transaction includes RTI’s participation in a $27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with […]
Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D […]
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery
First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization SAN FRANCISCO–Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the […]
Genedata Selector® deployed to streamline complex cell line development processes Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced an expansion of its collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company, to digitalize and automate complex cell line development processes. As part of this collaboration, Genedata Selector has been deployed […]
Lyon, France — Hitachi, Ltd. (TSE:6501, “Hitachi”) and Centre Léon Bérard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon […]
BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced that has established a Singapore-based entity in order to spearhead its activities in the Asia Pacific region, including China. To mark the occasion, BC Platforms is jointly hosting a launch event with the Finnish Government (Business Finland) and IQVIA […]
Mastermind Genomic Search Engine Now Filters Evidence by Phenotype – Critical for the Genetic Interpretation of Rare Diseases Genomenon® announced the release of Mastermind® version 2.0. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare […]
Leading manufacturer of therapeutic proteins implements Genedata Bioprocess to streamline development and manufacture of biopharmaceuticals Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of the world’s largest human protein manufacturers, has adopted the Genedata Bioprocess® platform to support the development and manufacturing of therapeutic proteins addressing […]
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems ST. LOUIS–PierianDx, the leading clinical genomics informatics company, today announced that it has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures that also includes existing investors Health […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
